Valuation: Tellgen Corporation

Market Cap 2.76B 410M 352M 330M 302M 569M 39.1B 572M 3.91B 1.51B 19.72B 1.54B 1.51B 65.33B P/E 2024
66.3x
P/E 2025 836x
Enterprise Value 2.55B 379M 325M 305M 279M 526M 36.11B 528M 3.61B 1.4B 18.22B 1.42B 1.39B 60.34B EV / Sales 2024
4.21x
EV / Sales 2025 7.5x
Free-Float
66.27%
Yield 2024
1.06%
Yield 2025 0.54%
1 day+20.00%
1 week+17.90%
Current month+31.71%
1 month+44.39%
3 months+8.36%
6 months-13.46%
Current year-11.91%
1 week 13.35
Extreme 13.35
16.2
1 month 11.04
Extreme 11.04
16.2
Current year 11.04
Extreme 11.04
22.87
1 year 11.04
Extreme 11.04
31.94
3 years 9.94
Extreme 9.94
32.8
5 years 9.94
Extreme 9.94
42.68
10 years 9.94
Extreme 9.94
50.25
Manager TitleAgeSince
Chief Executive Officer 56 05/11/2003
Director of Finance/CFO 50 08/06/2023
Corporate Officer/Principal 44 31/03/2009
Director TitleAgeSince
Chairman 56 05/11/2003
Director/Board Member 44 08/12/2020
Director/Board Member 63 13/08/2019
Change 5-day change 1-year change 3-year change Capi.($)
+20.00%+17.90%-43.65%-7.69% 385M
+3.51%+5.44%+171.53%+350.63% 22.13B
-1.59%+1.64%-37.77%-22.73% 10.37B
-1.31%+2.83%+355.81%+35.37% 8.43B
-5.18%+16.65%-30.84% - 7.92B
+0.27%+0.42%+81.29%+51.97% 6.58B
-0.12%-3.82%-14.67%-10.78% 6.01B
-0.39%+2.88%-16.36%-20.14% 4.39B
-2.48%-11.72%+56.86%+98.49% 4.09B
+0.26%-0.55%-19.52%-24.57% 2.91B
Average +1.28%+7.18%+50.27%+50.06% 7.32B
Weighted average by Cap. +0.07%+6.57%+91.45%+127.72%

Financials

2024 2025
Net sales 437M 64.96M 55.76M 52.33M 47.8M 90.21M 6.2B 90.64M 619M 240M 3.13B 244M 239M 10.35B 364M 54.11M 46.45M 43.59M 39.82M 75.14M 5.16B 75.5M 516M 200M 2.6B 203M 199M 8.62B
Net income 34.53M 5.14M 4.41M 4.14M 3.78M 7.13M 490M 7.17M 48.97M 18.98M 247M 19.29M 18.87M 819M 3.59M 534K 458K 430K 393K 741K 50.9M 745K 5.09M 1.97M 25.68M 2M 1.96M 85.05M
Net Debt -434M -64.59M -55.43M -52.03M -47.52M -89.68M -6.16B -90.12M -616M -239M -3.11B -242M -237M -10.29B -210M -31.28M -26.85M -25.2M -23.02M -43.44M -2.98B -43.65M -298M -116M -1.51B -117M -115M -4.99B
Logo Tellgen Corporation
Tellgen Corporation is a China-based company primarily engaged in the research and development, production and sales of in vitro diagnostic products. The Company's products mainly cover the fields of immunity, molecules and biochemistry, involving autoimmunity, tumors, cardiovascular, infection, hormones, metabolism and other fields. The Company's main products include tumor marker detection products, human papillomavirus (HPV) nucleic acid detection products, autoimmune disease detection products, methylation mutation detection products and other products. The Company conducts its business in the domestic and overseas markets.
Employees
683
Date Price Change Volume
26/08/26 CN¥17.24 +6.42% 39,028,830
25/08/26 CN¥16.20 +20.00% 11,268,764
24/08/26 CN¥13.50 -1.53% 3,601,780
21/08/26 CN¥13.71 -1.65% 4,240,840
20/08/26 CN¥13.94 +5.13% 6,371,037

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 300642 Stock